Informuta

Informuta develops RESISENSE, a diagnostic platform that uses machine learning and Next-Generation Sequencing (NGS) to analyze bacterial DNA. It uniquely predicts both current and future antibiotic resistance, allowing for more precise treatment decisions. This technology is designed to improve patient outcomes by enab

Informuta is active in the computational health space.

Profile

Informuta develops RESISENSE, a diagnostic platform that uses machine learning and Next-Generation Sequencing (NGS) to analyze bacterial DNA. It uniquely predicts both current and future antibiotic resistance, allowing for more precise treatment decisions. This technology is designed to improve patient outcomes by enabling faster, more accurate diagnostics and providing prognostics for the first time.

The company sits in the computational health segment, where it competes on its core product or service.

Directory data places it at the Creative Destruction Lab alumni company stage.

Website: informuta.com